We devised a diagnostic approach based on screening plasma for an Aspe
rgillus antigen with use of a sandwich enzyme-linked immunosorbent ass
ay (ELISA), thoracic computed tomographic scanning, and radionuclide i
maging for managing patients at risk for invasive aspergillosis. We us
ed a decision analytic model to compare this alternative strategy with
the conventional strategy, which relies only on the presence of clini
cal symptoms, persistent fever, and chest roentgenographic findings. U
se of the alternative strategy reduced the number of patients who woul
d receive antifungal treatment empirically, but this strategy was more
expensive. The specificity of the sandwich ELISA had a significant im
pact on cost, but the sensitivity did not. A 13% prevalence of infecti
on resulted in equal costs for both strategies. As much as 43.3% of th
e patients treated empirically could be given liposomal amphotericin B
(L-AmB) before the conventional strategy became the most expensive. T
he costs of the alternative strategy were less than those of the conve
ntional strategy when >5.3% of all patients, irrespective of strategy,
were treated with L-AmB.